Anteris Technologies Global Corp. — Board/Management Information 2017

Jun 8, 2017

==> picture [185 x 199] intentionally omitted <==

COMPANY ANNOUNCEMENT

Brisbane, Australia, 9 June, 2017

ADMEDUS APPOINTS DAVID ST. DENIS AS CHIEF OPERATING OFFICER

Admedus Limited (ASX:AHZ) today announced the appointment of David St. Denis as the Company’s new Chief Operating Officer. He succeeds Julian Chick, who has recently resigned. St. Denis will take up the role in July after relocating his family from Europe to Minneapolis where he will be based.

St. Denis is an accomplished senior healthcare leader with a systematic and metrics-driven approach spanning 20 years of proven business results at the regional and global levels within the life sciences and pharmaceutical sectors. Most recently at Merck in Germany, he headed commercial operations for Europe and Canada.

“The appointment of David St. Denis is a major milestone for our Company as we approach profitability,” says Admedus CEO Wayne Paterson. “David’s formidable sales and marketing capability will provide a powerful boost to our current momentum. New products, with productfocussed sales teams, have delivered stronger market presence and higher revenues. I expect this to continue at an accelerated rate with David driving the utilisation of new marketing tools, a sales model, and the CRM implementation and analysis we have recently established.”

The new COO will lead the Company’s global operations which will enable the CEO to focus on the long-term strategic goals that will ensure Admedus achieves its ‘Vision 2020’ objectives.

St. Denis has an extensive track record in charge of complex cross-functional and multi-cultural teams that have achieved impressive business objectives in both mature markets (US, Europe, Japan) and developing markets (China, India, Brazil, Russia, Mexico). His core competencies include operations management, strategy development, marketing and sales, new product introduction and launch excellence, market access and pricing.

He has a Bachelor of Science from the University of Connecticut, a Masters of Arts from Boston University and an MBA in Global Management and International Marketing from Babson College – Franklin W. Olin Graduate School of Business.

Paterson also thanked the outgoing COO for his service: “Julian has been a great advocate for Admedus over the past five years. On behalf of the Board, we offer our appreciation – and we wish him every success.”

Chick will continue to work with Admedus through the transition with St. Denis to ensure a smooth changeover in the role.

==> picture [154 x 11] intentionally omitted <==

==> picture [144 x 30] intentionally omitted <==

For more information, please contact:

Signal Leadership Communication Inc. Bob Pickard Tel: +1 (647) 822 1000 bob.pickard@signaleadership.com

About Admedus Limited

Admedus (ASX:AHZ) is a specialist healthcare company. Our focus is on investing in and developing next generation technologies with world class partners, acquiring strategic assets to grow product and service offerings and expanding revenues from our existing, profitable medical sales and distribution business. The company has assets from research & development through clinical development as well as sales, marketing and distribution.

Twitter: @Admedus Facebook: www.facebook.com/pages/Admedus Website: www.admedus.com

==> picture [153 x 11] intentionally omitted <==